This study examines the safety and acceptability of a novel "two dose" regimen of methotrexate to treat ectopic pregnancy.
The regimen is an attempt to create a middle ground between the 2 commonly used regimens - "single dose" and "multi dose". The "multi dose" regimen is more effective, but the "single dose" regimen is more convenient for patients and has fewer side effects.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
100
Two dose methotrexate
University of Southern California Women's and Children's Hospital
Los Angeles, California, United States
University of Miami
Miami, Florida, United States
University of Pennsylvania Reproductive Research Unit
Philadelphia, Pennsylvania, United States
Prevalence of side effects
Time frame: Till quantitative bhCG values fall to zero or below 5mIU/mL
Efficacy of treatment of ectopic pregnancy (defined as no surgical intervention)
Time frame: Till quantitative bhCG values fall to zero or below 5mIU/mL
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.